Global Metachromatic Leukodystrophy (MLD) Treatment Market Growth 2022-2028
The report requires updating with new data and is sent in 48 hours after order is placed.
As the global economy mends, the 2021 growth of Metachromatic Leukodystrophy (MLD) Treatment will have significant change from previous year. According to our (LP Information) latest study, the global Metachromatic Leukodystrophy (MLD) Treatment market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Metachromatic Leukodystrophy (MLD) Treatment market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.
The United States Metachromatic Leukodystrophy (MLD) Treatment market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Metachromatic Leukodystrophy (MLD) Treatment market, reaching US$ million by the year 2028. As for the Europe Metachromatic Leukodystrophy (MLD) Treatment landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Metachromatic Leukodystrophy (MLD) Treatment players cover ArmaGen Inc, GlaxoSmithKline Plc, Recursion Pharmaceuticals Inc, and RegenxBio Inc, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Metachromatic Leukodystrophy (MLD) Treatment market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
As the global economy mends, the 2021 growth of Metachromatic Leukodystrophy (MLD) Treatment will have significant change from previous year. According to our (LP Information) latest study, the global Metachromatic Leukodystrophy (MLD) Treatment market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Metachromatic Leukodystrophy (MLD) Treatment market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.
The United States Metachromatic Leukodystrophy (MLD) Treatment market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Metachromatic Leukodystrophy (MLD) Treatment market, reaching US$ million by the year 2028. As for the Europe Metachromatic Leukodystrophy (MLD) Treatment landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Metachromatic Leukodystrophy (MLD) Treatment players cover ArmaGen Inc, GlaxoSmithKline Plc, Recursion Pharmaceuticals Inc, and RegenxBio Inc, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Metachromatic Leukodystrophy (MLD) Treatment market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
- AGT-183
- DUOC-01
- GSK-2696274
- Others
- Hospital
- Clinic
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- ArmaGen Inc
- GlaxoSmithKline Plc
- Recursion Pharmaceuticals Inc
- RegenxBio Inc
- Takeda
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Metachromatic Leukodystrophy (MLD) Treatment Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Metachromatic Leukodystrophy (MLD) Treatment by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Metachromatic Leukodystrophy (MLD) Treatment by Country/Region, 2017, 2022 & 2028
2.2 Metachromatic Leukodystrophy (MLD) Treatment Segment by Type
2.2.1 AGT-183
2.2.2 DUOC-01
2.2.3 GSK-2696274
2.2.4 Others
2.3 Metachromatic Leukodystrophy (MLD) Treatment Sales by Type
2.3.1 Global Metachromatic Leukodystrophy (MLD) Treatment Sales Market Share by Type (2017-2022)
2.3.2 Global Metachromatic Leukodystrophy (MLD) Treatment Revenue and Market Share by Type (2017-2022)
2.3.3 Global Metachromatic Leukodystrophy (MLD) Treatment Sale Price by Type (2017-2022)
2.4 Metachromatic Leukodystrophy (MLD) Treatment Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Others
2.5 Metachromatic Leukodystrophy (MLD) Treatment Sales by Application
2.5.1 Global Metachromatic Leukodystrophy (MLD) Treatment Sale Market Share by Application (2017-2022)
2.5.2 Global Metachromatic Leukodystrophy (MLD) Treatment Revenue and Market Share by Application (2017-2022)
2.5.3 Global Metachromatic Leukodystrophy (MLD) Treatment Sale Price by Application (2017-2022)
3 GLOBAL METACHROMATIC LEUKODYSTROPHY (MLD) TREATMENT BY COMPANY
3.1 Global Metachromatic Leukodystrophy (MLD) Treatment Breakdown Data by Company
3.1.1 Global Metachromatic Leukodystrophy (MLD) Treatment Annual Sales by Company (2020-2022)
3.1.2 Global Metachromatic Leukodystrophy (MLD) Treatment Sales Market Share by Company (2020-2022)
3.2 Global Metachromatic Leukodystrophy (MLD) Treatment Annual Revenue by Company (2020-2022)
3.2.1 Global Metachromatic Leukodystrophy (MLD) Treatment Revenue by Company (2020-2022)
3.2.2 Global Metachromatic Leukodystrophy (MLD) Treatment Revenue Market Share by Company (2020-2022)
3.3 Global Metachromatic Leukodystrophy (MLD) Treatment Sale Price by Company
3.4 Key Manufacturers Metachromatic Leukodystrophy (MLD) Treatment Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Metachromatic Leukodystrophy (MLD) Treatment Product Location Distribution
3.4.2 Players Metachromatic Leukodystrophy (MLD) Treatment Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR METACHROMATIC LEUKODYSTROPHY (MLD) TREATMENT BY GEOGRAPHIC REGION
4.1 World Historic Metachromatic Leukodystrophy (MLD) Treatment Market Size by Geographic Region (2017-2022)
4.1.1 Global Metachromatic Leukodystrophy (MLD) Treatment Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Metachromatic Leukodystrophy (MLD) Treatment Annual Revenue by Geographic Region
4.2 World Historic Metachromatic Leukodystrophy (MLD) Treatment Market Size by Country/Region (2017-2022)
4.2.1 Global Metachromatic Leukodystrophy (MLD) Treatment Annual Sales by Country/Region (2017-2022)
4.2.2 Global Metachromatic Leukodystrophy (MLD) Treatment Annual Revenue by Country/Region
4.3 Americas Metachromatic Leukodystrophy (MLD) Treatment Sales Growth
4.4 APAC Metachromatic Leukodystrophy (MLD) Treatment Sales Growth
4.5 Europe Metachromatic Leukodystrophy (MLD) Treatment Sales Growth
4.6 Middle East & Africa Metachromatic Leukodystrophy (MLD) Treatment Sales Growth
5 AMERICAS
5.1 Americas Metachromatic Leukodystrophy (MLD) Treatment Sales by Country
5.1.1 Americas Metachromatic Leukodystrophy (MLD) Treatment Sales by Country (2017-2022)
5.1.2 Americas Metachromatic Leukodystrophy (MLD) Treatment Revenue by Country (2017-2022)
5.2 Americas Metachromatic Leukodystrophy (MLD) Treatment Sales by Type
5.3 Americas Metachromatic Leukodystrophy (MLD) Treatment Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Metachromatic Leukodystrophy (MLD) Treatment Sales by Region
6.1.1 APAC Metachromatic Leukodystrophy (MLD) Treatment Sales by Region (2017-2022)
6.1.2 APAC Metachromatic Leukodystrophy (MLD) Treatment Revenue by Region (2017-2022)
6.2 APAC Metachromatic Leukodystrophy (MLD) Treatment Sales by Type
6.3 APAC Metachromatic Leukodystrophy (MLD) Treatment Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Metachromatic Leukodystrophy (MLD) Treatment by Country
7.1.1 Europe Metachromatic Leukodystrophy (MLD) Treatment Sales by Country (2017-2022)
7.1.2 Europe Metachromatic Leukodystrophy (MLD) Treatment Revenue by Country (2017-2022)
7.2 Europe Metachromatic Leukodystrophy (MLD) Treatment Sales by Type
7.3 Europe Metachromatic Leukodystrophy (MLD) Treatment Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Metachromatic Leukodystrophy (MLD) Treatment by Country
8.1.1 Middle East & Africa Metachromatic Leukodystrophy (MLD) Treatment Sales by Country (2017-2022)
8.1.2 Middle East & Africa Metachromatic Leukodystrophy (MLD) Treatment Revenue by Country (2017-2022)
8.2 Middle East & Africa Metachromatic Leukodystrophy (MLD) Treatment Sales by Type
8.3 Middle East & Africa Metachromatic Leukodystrophy (MLD) Treatment Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Metachromatic Leukodystrophy (MLD) Treatment
10.3 Manufacturing Process Analysis of Metachromatic Leukodystrophy (MLD) Treatment
10.4 Industry Chain Structure of Metachromatic Leukodystrophy (MLD) Treatment
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Metachromatic Leukodystrophy (MLD) Treatment Distributors
11.3 Metachromatic Leukodystrophy (MLD) Treatment Customer
12 WORLD FORECAST REVIEW FOR METACHROMATIC LEUKODYSTROPHY (MLD) TREATMENT BY GEOGRAPHIC REGION
12.1 Global Metachromatic Leukodystrophy (MLD) Treatment Market Size Forecast by Region
12.1.1 Global Metachromatic Leukodystrophy (MLD) Treatment Forecast by Region (2023-2028)
12.1.2 Global Metachromatic Leukodystrophy (MLD) Treatment Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Metachromatic Leukodystrophy (MLD) Treatment Forecast by Type
12.7 Global Metachromatic Leukodystrophy (MLD) Treatment Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 ArmaGen Inc
13.1.1 ArmaGen Inc Company Information
13.1.2 ArmaGen Inc Metachromatic Leukodystrophy (MLD) Treatment Product Offered
13.1.3 ArmaGen Inc Metachromatic Leukodystrophy (MLD) Treatment Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 ArmaGen Inc Main Business Overview
13.1.5 ArmaGen Inc Latest Developments
13.2 GlaxoSmithKline Plc
13.2.1 GlaxoSmithKline Plc Company Information
13.2.2 GlaxoSmithKline Plc Metachromatic Leukodystrophy (MLD) Treatment Product Offered
13.2.3 GlaxoSmithKline Plc Metachromatic Leukodystrophy (MLD) Treatment Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 GlaxoSmithKline Plc Main Business Overview
13.2.5 GlaxoSmithKline Plc Latest Developments
13.3 Recursion Pharmaceuticals Inc
13.3.1 Recursion Pharmaceuticals Inc Company Information
13.3.2 Recursion Pharmaceuticals Inc Metachromatic Leukodystrophy (MLD) Treatment Product Offered
13.3.3 Recursion Pharmaceuticals Inc Metachromatic Leukodystrophy (MLD) Treatment Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Recursion Pharmaceuticals Inc Main Business Overview
13.3.5 Recursion Pharmaceuticals Inc Latest Developments
13.4 RegenxBio Inc
13.4.1 RegenxBio Inc Company Information
13.4.2 RegenxBio Inc Metachromatic Leukodystrophy (MLD) Treatment Product Offered
13.4.3 RegenxBio Inc Metachromatic Leukodystrophy (MLD) Treatment Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 RegenxBio Inc Main Business Overview
13.4.5 RegenxBio Inc Latest Developments
13.5 Takeda
13.5.1 Takeda Company Information
13.5.2 Takeda Metachromatic Leukodystrophy (MLD) Treatment Product Offered
13.5.3 Takeda Metachromatic Leukodystrophy (MLD) Treatment Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Takeda Main Business Overview
13.5.5 Takeda Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Metachromatic Leukodystrophy (MLD) Treatment Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Metachromatic Leukodystrophy (MLD) Treatment by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Metachromatic Leukodystrophy (MLD) Treatment by Country/Region, 2017, 2022 & 2028
2.2 Metachromatic Leukodystrophy (MLD) Treatment Segment by Type
2.2.1 AGT-183
2.2.2 DUOC-01
2.2.3 GSK-2696274
2.2.4 Others
2.3 Metachromatic Leukodystrophy (MLD) Treatment Sales by Type
2.3.1 Global Metachromatic Leukodystrophy (MLD) Treatment Sales Market Share by Type (2017-2022)
2.3.2 Global Metachromatic Leukodystrophy (MLD) Treatment Revenue and Market Share by Type (2017-2022)
2.3.3 Global Metachromatic Leukodystrophy (MLD) Treatment Sale Price by Type (2017-2022)
2.4 Metachromatic Leukodystrophy (MLD) Treatment Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Others
2.5 Metachromatic Leukodystrophy (MLD) Treatment Sales by Application
2.5.1 Global Metachromatic Leukodystrophy (MLD) Treatment Sale Market Share by Application (2017-2022)
2.5.2 Global Metachromatic Leukodystrophy (MLD) Treatment Revenue and Market Share by Application (2017-2022)
2.5.3 Global Metachromatic Leukodystrophy (MLD) Treatment Sale Price by Application (2017-2022)
3 GLOBAL METACHROMATIC LEUKODYSTROPHY (MLD) TREATMENT BY COMPANY
3.1 Global Metachromatic Leukodystrophy (MLD) Treatment Breakdown Data by Company
3.1.1 Global Metachromatic Leukodystrophy (MLD) Treatment Annual Sales by Company (2020-2022)
3.1.2 Global Metachromatic Leukodystrophy (MLD) Treatment Sales Market Share by Company (2020-2022)
3.2 Global Metachromatic Leukodystrophy (MLD) Treatment Annual Revenue by Company (2020-2022)
3.2.1 Global Metachromatic Leukodystrophy (MLD) Treatment Revenue by Company (2020-2022)
3.2.2 Global Metachromatic Leukodystrophy (MLD) Treatment Revenue Market Share by Company (2020-2022)
3.3 Global Metachromatic Leukodystrophy (MLD) Treatment Sale Price by Company
3.4 Key Manufacturers Metachromatic Leukodystrophy (MLD) Treatment Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Metachromatic Leukodystrophy (MLD) Treatment Product Location Distribution
3.4.2 Players Metachromatic Leukodystrophy (MLD) Treatment Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR METACHROMATIC LEUKODYSTROPHY (MLD) TREATMENT BY GEOGRAPHIC REGION
4.1 World Historic Metachromatic Leukodystrophy (MLD) Treatment Market Size by Geographic Region (2017-2022)
4.1.1 Global Metachromatic Leukodystrophy (MLD) Treatment Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Metachromatic Leukodystrophy (MLD) Treatment Annual Revenue by Geographic Region
4.2 World Historic Metachromatic Leukodystrophy (MLD) Treatment Market Size by Country/Region (2017-2022)
4.2.1 Global Metachromatic Leukodystrophy (MLD) Treatment Annual Sales by Country/Region (2017-2022)
4.2.2 Global Metachromatic Leukodystrophy (MLD) Treatment Annual Revenue by Country/Region
4.3 Americas Metachromatic Leukodystrophy (MLD) Treatment Sales Growth
4.4 APAC Metachromatic Leukodystrophy (MLD) Treatment Sales Growth
4.5 Europe Metachromatic Leukodystrophy (MLD) Treatment Sales Growth
4.6 Middle East & Africa Metachromatic Leukodystrophy (MLD) Treatment Sales Growth
5 AMERICAS
5.1 Americas Metachromatic Leukodystrophy (MLD) Treatment Sales by Country
5.1.1 Americas Metachromatic Leukodystrophy (MLD) Treatment Sales by Country (2017-2022)
5.1.2 Americas Metachromatic Leukodystrophy (MLD) Treatment Revenue by Country (2017-2022)
5.2 Americas Metachromatic Leukodystrophy (MLD) Treatment Sales by Type
5.3 Americas Metachromatic Leukodystrophy (MLD) Treatment Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Metachromatic Leukodystrophy (MLD) Treatment Sales by Region
6.1.1 APAC Metachromatic Leukodystrophy (MLD) Treatment Sales by Region (2017-2022)
6.1.2 APAC Metachromatic Leukodystrophy (MLD) Treatment Revenue by Region (2017-2022)
6.2 APAC Metachromatic Leukodystrophy (MLD) Treatment Sales by Type
6.3 APAC Metachromatic Leukodystrophy (MLD) Treatment Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Metachromatic Leukodystrophy (MLD) Treatment by Country
7.1.1 Europe Metachromatic Leukodystrophy (MLD) Treatment Sales by Country (2017-2022)
7.1.2 Europe Metachromatic Leukodystrophy (MLD) Treatment Revenue by Country (2017-2022)
7.2 Europe Metachromatic Leukodystrophy (MLD) Treatment Sales by Type
7.3 Europe Metachromatic Leukodystrophy (MLD) Treatment Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Metachromatic Leukodystrophy (MLD) Treatment by Country
8.1.1 Middle East & Africa Metachromatic Leukodystrophy (MLD) Treatment Sales by Country (2017-2022)
8.1.2 Middle East & Africa Metachromatic Leukodystrophy (MLD) Treatment Revenue by Country (2017-2022)
8.2 Middle East & Africa Metachromatic Leukodystrophy (MLD) Treatment Sales by Type
8.3 Middle East & Africa Metachromatic Leukodystrophy (MLD) Treatment Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Metachromatic Leukodystrophy (MLD) Treatment
10.3 Manufacturing Process Analysis of Metachromatic Leukodystrophy (MLD) Treatment
10.4 Industry Chain Structure of Metachromatic Leukodystrophy (MLD) Treatment
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Metachromatic Leukodystrophy (MLD) Treatment Distributors
11.3 Metachromatic Leukodystrophy (MLD) Treatment Customer
12 WORLD FORECAST REVIEW FOR METACHROMATIC LEUKODYSTROPHY (MLD) TREATMENT BY GEOGRAPHIC REGION
12.1 Global Metachromatic Leukodystrophy (MLD) Treatment Market Size Forecast by Region
12.1.1 Global Metachromatic Leukodystrophy (MLD) Treatment Forecast by Region (2023-2028)
12.1.2 Global Metachromatic Leukodystrophy (MLD) Treatment Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Metachromatic Leukodystrophy (MLD) Treatment Forecast by Type
12.7 Global Metachromatic Leukodystrophy (MLD) Treatment Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 ArmaGen Inc
13.1.1 ArmaGen Inc Company Information
13.1.2 ArmaGen Inc Metachromatic Leukodystrophy (MLD) Treatment Product Offered
13.1.3 ArmaGen Inc Metachromatic Leukodystrophy (MLD) Treatment Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 ArmaGen Inc Main Business Overview
13.1.5 ArmaGen Inc Latest Developments
13.2 GlaxoSmithKline Plc
13.2.1 GlaxoSmithKline Plc Company Information
13.2.2 GlaxoSmithKline Plc Metachromatic Leukodystrophy (MLD) Treatment Product Offered
13.2.3 GlaxoSmithKline Plc Metachromatic Leukodystrophy (MLD) Treatment Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 GlaxoSmithKline Plc Main Business Overview
13.2.5 GlaxoSmithKline Plc Latest Developments
13.3 Recursion Pharmaceuticals Inc
13.3.1 Recursion Pharmaceuticals Inc Company Information
13.3.2 Recursion Pharmaceuticals Inc Metachromatic Leukodystrophy (MLD) Treatment Product Offered
13.3.3 Recursion Pharmaceuticals Inc Metachromatic Leukodystrophy (MLD) Treatment Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Recursion Pharmaceuticals Inc Main Business Overview
13.3.5 Recursion Pharmaceuticals Inc Latest Developments
13.4 RegenxBio Inc
13.4.1 RegenxBio Inc Company Information
13.4.2 RegenxBio Inc Metachromatic Leukodystrophy (MLD) Treatment Product Offered
13.4.3 RegenxBio Inc Metachromatic Leukodystrophy (MLD) Treatment Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 RegenxBio Inc Main Business Overview
13.4.5 RegenxBio Inc Latest Developments
13.5 Takeda
13.5.1 Takeda Company Information
13.5.2 Takeda Metachromatic Leukodystrophy (MLD) Treatment Product Offered
13.5.3 Takeda Metachromatic Leukodystrophy (MLD) Treatment Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Takeda Main Business Overview
13.5.5 Takeda Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Metachromatic Leukodystrophy (MLD) Treatment Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Metachromatic Leukodystrophy (MLD) Treatment Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of AGT-183
Table 4. Major Players of DUOC-01
Table 5. Major Players of GSK-2696274
Table 6. Major Players of Others
Table 7. Global Metachromatic Leukodystrophy (MLD) Treatment Sales by Type (2017-2022) & (K Pcs)
Table 8. Global Metachromatic Leukodystrophy (MLD) Treatment Sales Market Share by Type (2017-2022)
Table 9. Global Metachromatic Leukodystrophy (MLD) Treatment Revenue by Type (2017-2022) & ($ million)
Table 10. Global Metachromatic Leukodystrophy (MLD) Treatment Revenue Market Share by Type (2017-2022)
Table 11. Global Metachromatic Leukodystrophy (MLD) Treatment Sale Price by Type (2017-2022) & (USD/Pcs)
Table 12. Global Metachromatic Leukodystrophy (MLD) Treatment Sales by Application (2017-2022) & (K Pcs)
Table 13. Global Metachromatic Leukodystrophy (MLD) Treatment Sales Market Share by Application (2017-2022)
Table 14. Global Metachromatic Leukodystrophy (MLD) Treatment Revenue by Application (2017-2022)
Table 15. Global Metachromatic Leukodystrophy (MLD) Treatment Revenue Market Share by Application (2017-2022)
Table 16. Global Metachromatic Leukodystrophy (MLD) Treatment Sale Price by Application (2017-2022) & (USD/Pcs)
Table 17. Global Metachromatic Leukodystrophy (MLD) Treatment Sales by Company (2020-2022) & (K Pcs)
Table 18. Global Metachromatic Leukodystrophy (MLD) Treatment Sales Market Share by Company (2020-2022)
Table 19. Global Metachromatic Leukodystrophy (MLD) Treatment Revenue by Company (2020-2022) ($ Millions)
Table 20. Global Metachromatic Leukodystrophy (MLD) Treatment Revenue Market Share by Company (2020-2022)
Table 21. Global Metachromatic Leukodystrophy (MLD) Treatment Sale Price by Company (2020-2022) & (USD/Pcs)
Table 22. Key Manufacturers Metachromatic Leukodystrophy (MLD) Treatment Producing Area Distribution and Sales Area
Table 23. Players Metachromatic Leukodystrophy (MLD) Treatment Products Offered
Table 24. Metachromatic Leukodystrophy (MLD) Treatment Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global Metachromatic Leukodystrophy (MLD) Treatment Sales by Geographic Region (2017-2022) & (K Pcs)
Table 28. Global Metachromatic Leukodystrophy (MLD) Treatment Sales Market Share Geographic Region (2017-2022)
Table 29. Global Metachromatic Leukodystrophy (MLD) Treatment Revenue by Geographic Region (2017-2022) & ($ millions)
Table 30. Global Metachromatic Leukodystrophy (MLD) Treatment Revenue Market Share by Geographic Region (2017-2022)
Table 31. Global Metachromatic Leukodystrophy (MLD) Treatment Sales by Country/Region (2017-2022) & (K Pcs)
Table 32. Global Metachromatic Leukodystrophy (MLD) Treatment Sales Market Share by Country/Region (2017-2022)
Table 33. Global Metachromatic Leukodystrophy (MLD) Treatment Revenue by Country/Region (2017-2022) & ($ millions)
Table 34. Global Metachromatic Leukodystrophy (MLD) Treatment Revenue Market Share by Country/Region (2017-2022)
Table 35. Americas Metachromatic Leukodystrophy (MLD) Treatment Sales by Country (2017-2022) & (K Pcs)
Table 36. Americas Metachromatic Leukodystrophy (MLD) Treatment Sales Market Share by Country (2017-2022)
Table 37. Americas Metachromatic Leukodystrophy (MLD) Treatment Revenue by Country (2017-2022) & ($ Millions)
Table 38. Americas Metachromatic Leukodystrophy (MLD) Treatment Revenue Market Share by Country (2017-2022)
Table 39. Americas Metachromatic Leukodystrophy (MLD) Treatment Sales by Type (2017-2022) & (K Pcs)
Table 40. Americas Metachromatic Leukodystrophy (MLD) Treatment Sales Market Share by Type (2017-2022)
Table 41. Americas Metachromatic Leukodystrophy (MLD) Treatment Sales by Application (2017-2022) & (K Pcs)
Table 42. Americas Metachromatic Leukodystrophy (MLD) Treatment Sales Market Share by Application (2017-2022)
Table 43. APAC Metachromatic Leukodystrophy (MLD) Treatment Sales by Region (2017-2022) & (K Pcs)
Table 44. APAC Metachromatic Leukodystrophy (MLD) Treatment Sales Market Share by Region (2017-2022)
Table 45. APAC Metachromatic Leukodystrophy (MLD) Treatment Revenue by Region (2017-2022) & ($ Millions)
Table 46. APAC Metachromatic Leukodystrophy (MLD) Treatment Revenue Market Share by Region (2017-2022)
Table 47. APAC Metachromatic Leukodystrophy (MLD) Treatment Sales by Type (2017-2022) & (K Pcs)
Table 48. APAC Metachromatic Leukodystrophy (MLD) Treatment Sales Market Share by Type (2017-2022)
Table 49. APAC Metachromatic Leukodystrophy (MLD) Treatment Sales by Application (2017-2022) & (K Pcs)
Table 50. APAC Metachromatic Leukodystrophy (MLD) Treatment Sales Market Share by Application (2017-2022)
Table 51. Europe Metachromatic Leukodystrophy (MLD) Treatment Sales by Country (2017-2022) & (K Pcs)
Table 52. Europe Metachromatic Leukodystrophy (MLD) Treatment Sales Market Share by Country (2017-2022)
Table 53. Europe Metachromatic Leukodystrophy (MLD) Treatment Revenue by Country (2017-2022) & ($ Millions)
Table 54. Europe Metachromatic Leukodystrophy (MLD) Treatment Revenue Market Share by Country (2017-2022)
Table 55. Europe Metachromatic Leukodystrophy (MLD) Treatment Sales by Type (2017-2022) & (K Pcs)
Table 56. Europe Metachromatic Leukodystrophy (MLD) Treatment Sales Market Share by Type (2017-2022)
Table 57. Europe Metachromatic Leukodystrophy (MLD) Treatment Sales by Application (2017-2022) & (K Pcs)
Table 58. Europe Metachromatic Leukodystrophy (MLD) Treatment Sales Market Share by Application (2017-2022)
Table 59. Middle East & Africa Metachromatic Leukodystrophy (MLD) Treatment Sales by Country (2017-2022) & (K Pcs)
Table 60. Middle East & Africa Metachromatic Leukodystrophy (MLD) Treatment Sales Market Share by Country (2017-2022)
Table 61. Middle East & Africa Metachromatic Leukodystrophy (MLD) Treatment Revenue by Country (2017-2022) & ($ Millions)
Table 62. Middle East & Africa Metachromatic Leukodystrophy (MLD) Treatment Revenue Market Share by Country (2017-2022)
Table 63. Middle East & Africa Metachromatic Leukodystrophy (MLD) Treatment Sales by Type (2017-2022) & (K Pcs)
Table 64. Middle East & Africa Metachromatic Leukodystrophy (MLD) Treatment Sales Market Share by Type (2017-2022)
Table 65. Middle East & Africa Metachromatic Leukodystrophy (MLD) Treatment Sales by Application (2017-2022) & (K Pcs)
Table 66. Middle East & Africa Metachromatic Leukodystrophy (MLD) Treatment Sales Market Share by Application (2017-2022)
Table 67. Key Market Drivers & Growth Opportunities of Metachromatic Leukodystrophy (MLD) Treatment
Table 68. Key Market Challenges & Risks of Metachromatic Leukodystrophy (MLD) Treatment
Table 69. Key Industry Trends of Metachromatic Leukodystrophy (MLD) Treatment
Table 70. Metachromatic Leukodystrophy (MLD) Treatment Raw Material
Table 71. Key Suppliers of Raw Materials
Table 72. Metachromatic Leukodystrophy (MLD) Treatment Distributors List
Table 73. Metachromatic Leukodystrophy (MLD) Treatment Customer List
Table 74. Global Metachromatic Leukodystrophy (MLD) Treatment Sales Forecast by Region (2023-2028) & (K Pcs)
Table 75. Global Metachromatic Leukodystrophy (MLD) Treatment Sales Market Forecast by Region
Table 76. Global Metachromatic Leukodystrophy (MLD) Treatment Revenue Forecast by Region (2023-2028) & ($ millions)
Table 77. Global Metachromatic Leukodystrophy (MLD) Treatment Revenue Market Share Forecast by Region (2023-2028)
Table 78. Americas Metachromatic Leukodystrophy (MLD) Treatment Sales Forecast by Country (2023-2028) & (K Pcs)
Table 79. Americas Metachromatic Leukodystrophy (MLD) Treatment Revenue Forecast by Country (2023-2028) & ($ millions)
Table 80. APAC Metachromatic Leukodystrophy (MLD) Treatment Sales Forecast by Region (2023-2028) & (K Pcs)
Table 81. APAC Metachromatic Leukodystrophy (MLD) Treatment Revenue Forecast by Region (2023-2028) & ($ millions)
Table 82. Europe Metachromatic Leukodystrophy (MLD) Treatment Sales Forecast by Country (2023-2028) & (K Pcs)
Table 83. Europe Metachromatic Leukodystrophy (MLD) Treatment Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Middle East & Africa Metachromatic Leukodystrophy (MLD) Treatment Sales Forecast by Country (2023-2028) & (K Pcs)
Table 85. Middle East & Africa Metachromatic Leukodystrophy (MLD) Treatment Revenue Forecast by Country (2023-2028) & ($ millions)
Table 86. Global Metachromatic Leukodystrophy (MLD) Treatment Sales Forecast by Type (2023-2028) & (K Pcs)
Table 87. Global Metachromatic Leukodystrophy (MLD) Treatment Sales Market Share Forecast by Type (2023-2028)
Table 88. Global Metachromatic Leukodystrophy (MLD) Treatment Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 89. Global Metachromatic Leukodystrophy (MLD) Treatment Revenue Market Share Forecast by Type (2023-2028)
Table 90. Global Metachromatic Leukodystrophy (MLD) Treatment Sales Forecast by Application (2023-2028) & (K Pcs)
Table 91. Global Metachromatic Leukodystrophy (MLD) Treatment Sales Market Share Forecast by Application (2023-2028)
Table 92. Global Metachromatic Leukodystrophy (MLD) Treatment Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 93. Global Metachromatic Leukodystrophy (MLD) Treatment Revenue Market Share Forecast by Application (2023-2028)
Table 94. ArmaGen Inc Basic Information, Metachromatic Leukodystrophy (MLD) Treatment Manufacturing Base, Sales Area and Its Competitors
Table 95. ArmaGen Inc Metachromatic Leukodystrophy (MLD) Treatment Product Offered
Table 96. ArmaGen Inc Metachromatic Leukodystrophy (MLD) Treatment Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 97. ArmaGen Inc Main Business
Table 98. ArmaGen Inc Latest Developments
Table 99. GlaxoSmithKline Plc Basic Information, Metachromatic Leukodystrophy (MLD) Treatment Manufacturing Base, Sales Area and Its Competitors
Table 100. GlaxoSmithKline Plc Metachromatic Leukodystrophy (MLD) Treatment Product Offered
Table 101. GlaxoSmithKline Plc Metachromatic Leukodystrophy (MLD) Treatment Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 102. GlaxoSmithKline Plc Main Business
Table 103. GlaxoSmithKline Plc Latest Developments
Table 104. Recursion Pharmaceuticals Inc Basic Information, Metachromatic Leukodystrophy (MLD) Treatment Manufacturing Base, Sales Area and Its Competitors
Table 105. Recursion Pharmaceuticals Inc Metachromatic Leukodystrophy (MLD) Treatment Product Offered
Table 106. Recursion Pharmaceuticals Inc Metachromatic Leukodystrophy (MLD) Treatment Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 107. Recursion Pharmaceuticals Inc Main Business
Table 108. Recursion Pharmaceuticals Inc Latest Developments
Table 109. RegenxBio Inc Basic Information, Metachromatic Leukodystrophy (MLD) Treatment Manufacturing Base, Sales Area and Its Competitors
Table 110. RegenxBio Inc Metachromatic Leukodystrophy (MLD) Treatment Product Offered
Table 111. RegenxBio Inc Metachromatic Leukodystrophy (MLD) Treatment Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 112. RegenxBio Inc Main Business
Table 113. RegenxBio Inc Latest Developments
Table 114. Takeda Basic Information, Metachromatic Leukodystrophy (MLD) Treatment Manufacturing Base, Sales Area and Its Competitors
Table 115. Takeda Metachromatic Leukodystrophy (MLD) Treatment Product Offered
Table 116. Takeda Metachromatic Leukodystrophy (MLD) Treatment Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 117. Takeda Main Business
Table 118. Takeda Latest Developments
Table 1. Metachromatic Leukodystrophy (MLD) Treatment Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Metachromatic Leukodystrophy (MLD) Treatment Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of AGT-183
Table 4. Major Players of DUOC-01
Table 5. Major Players of GSK-2696274
Table 6. Major Players of Others
Table 7. Global Metachromatic Leukodystrophy (MLD) Treatment Sales by Type (2017-2022) & (K Pcs)
Table 8. Global Metachromatic Leukodystrophy (MLD) Treatment Sales Market Share by Type (2017-2022)
Table 9. Global Metachromatic Leukodystrophy (MLD) Treatment Revenue by Type (2017-2022) & ($ million)
Table 10. Global Metachromatic Leukodystrophy (MLD) Treatment Revenue Market Share by Type (2017-2022)
Table 11. Global Metachromatic Leukodystrophy (MLD) Treatment Sale Price by Type (2017-2022) & (USD/Pcs)
Table 12. Global Metachromatic Leukodystrophy (MLD) Treatment Sales by Application (2017-2022) & (K Pcs)
Table 13. Global Metachromatic Leukodystrophy (MLD) Treatment Sales Market Share by Application (2017-2022)
Table 14. Global Metachromatic Leukodystrophy (MLD) Treatment Revenue by Application (2017-2022)
Table 15. Global Metachromatic Leukodystrophy (MLD) Treatment Revenue Market Share by Application (2017-2022)
Table 16. Global Metachromatic Leukodystrophy (MLD) Treatment Sale Price by Application (2017-2022) & (USD/Pcs)
Table 17. Global Metachromatic Leukodystrophy (MLD) Treatment Sales by Company (2020-2022) & (K Pcs)
Table 18. Global Metachromatic Leukodystrophy (MLD) Treatment Sales Market Share by Company (2020-2022)
Table 19. Global Metachromatic Leukodystrophy (MLD) Treatment Revenue by Company (2020-2022) ($ Millions)
Table 20. Global Metachromatic Leukodystrophy (MLD) Treatment Revenue Market Share by Company (2020-2022)
Table 21. Global Metachromatic Leukodystrophy (MLD) Treatment Sale Price by Company (2020-2022) & (USD/Pcs)
Table 22. Key Manufacturers Metachromatic Leukodystrophy (MLD) Treatment Producing Area Distribution and Sales Area
Table 23. Players Metachromatic Leukodystrophy (MLD) Treatment Products Offered
Table 24. Metachromatic Leukodystrophy (MLD) Treatment Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global Metachromatic Leukodystrophy (MLD) Treatment Sales by Geographic Region (2017-2022) & (K Pcs)
Table 28. Global Metachromatic Leukodystrophy (MLD) Treatment Sales Market Share Geographic Region (2017-2022)
Table 29. Global Metachromatic Leukodystrophy (MLD) Treatment Revenue by Geographic Region (2017-2022) & ($ millions)
Table 30. Global Metachromatic Leukodystrophy (MLD) Treatment Revenue Market Share by Geographic Region (2017-2022)
Table 31. Global Metachromatic Leukodystrophy (MLD) Treatment Sales by Country/Region (2017-2022) & (K Pcs)
Table 32. Global Metachromatic Leukodystrophy (MLD) Treatment Sales Market Share by Country/Region (2017-2022)
Table 33. Global Metachromatic Leukodystrophy (MLD) Treatment Revenue by Country/Region (2017-2022) & ($ millions)
Table 34. Global Metachromatic Leukodystrophy (MLD) Treatment Revenue Market Share by Country/Region (2017-2022)
Table 35. Americas Metachromatic Leukodystrophy (MLD) Treatment Sales by Country (2017-2022) & (K Pcs)
Table 36. Americas Metachromatic Leukodystrophy (MLD) Treatment Sales Market Share by Country (2017-2022)
Table 37. Americas Metachromatic Leukodystrophy (MLD) Treatment Revenue by Country (2017-2022) & ($ Millions)
Table 38. Americas Metachromatic Leukodystrophy (MLD) Treatment Revenue Market Share by Country (2017-2022)
Table 39. Americas Metachromatic Leukodystrophy (MLD) Treatment Sales by Type (2017-2022) & (K Pcs)
Table 40. Americas Metachromatic Leukodystrophy (MLD) Treatment Sales Market Share by Type (2017-2022)
Table 41. Americas Metachromatic Leukodystrophy (MLD) Treatment Sales by Application (2017-2022) & (K Pcs)
Table 42. Americas Metachromatic Leukodystrophy (MLD) Treatment Sales Market Share by Application (2017-2022)
Table 43. APAC Metachromatic Leukodystrophy (MLD) Treatment Sales by Region (2017-2022) & (K Pcs)
Table 44. APAC Metachromatic Leukodystrophy (MLD) Treatment Sales Market Share by Region (2017-2022)
Table 45. APAC Metachromatic Leukodystrophy (MLD) Treatment Revenue by Region (2017-2022) & ($ Millions)
Table 46. APAC Metachromatic Leukodystrophy (MLD) Treatment Revenue Market Share by Region (2017-2022)
Table 47. APAC Metachromatic Leukodystrophy (MLD) Treatment Sales by Type (2017-2022) & (K Pcs)
Table 48. APAC Metachromatic Leukodystrophy (MLD) Treatment Sales Market Share by Type (2017-2022)
Table 49. APAC Metachromatic Leukodystrophy (MLD) Treatment Sales by Application (2017-2022) & (K Pcs)
Table 50. APAC Metachromatic Leukodystrophy (MLD) Treatment Sales Market Share by Application (2017-2022)
Table 51. Europe Metachromatic Leukodystrophy (MLD) Treatment Sales by Country (2017-2022) & (K Pcs)
Table 52. Europe Metachromatic Leukodystrophy (MLD) Treatment Sales Market Share by Country (2017-2022)
Table 53. Europe Metachromatic Leukodystrophy (MLD) Treatment Revenue by Country (2017-2022) & ($ Millions)
Table 54. Europe Metachromatic Leukodystrophy (MLD) Treatment Revenue Market Share by Country (2017-2022)
Table 55. Europe Metachromatic Leukodystrophy (MLD) Treatment Sales by Type (2017-2022) & (K Pcs)
Table 56. Europe Metachromatic Leukodystrophy (MLD) Treatment Sales Market Share by Type (2017-2022)
Table 57. Europe Metachromatic Leukodystrophy (MLD) Treatment Sales by Application (2017-2022) & (K Pcs)
Table 58. Europe Metachromatic Leukodystrophy (MLD) Treatment Sales Market Share by Application (2017-2022)
Table 59. Middle East & Africa Metachromatic Leukodystrophy (MLD) Treatment Sales by Country (2017-2022) & (K Pcs)
Table 60. Middle East & Africa Metachromatic Leukodystrophy (MLD) Treatment Sales Market Share by Country (2017-2022)
Table 61. Middle East & Africa Metachromatic Leukodystrophy (MLD) Treatment Revenue by Country (2017-2022) & ($ Millions)
Table 62. Middle East & Africa Metachromatic Leukodystrophy (MLD) Treatment Revenue Market Share by Country (2017-2022)
Table 63. Middle East & Africa Metachromatic Leukodystrophy (MLD) Treatment Sales by Type (2017-2022) & (K Pcs)
Table 64. Middle East & Africa Metachromatic Leukodystrophy (MLD) Treatment Sales Market Share by Type (2017-2022)
Table 65. Middle East & Africa Metachromatic Leukodystrophy (MLD) Treatment Sales by Application (2017-2022) & (K Pcs)
Table 66. Middle East & Africa Metachromatic Leukodystrophy (MLD) Treatment Sales Market Share by Application (2017-2022)
Table 67. Key Market Drivers & Growth Opportunities of Metachromatic Leukodystrophy (MLD) Treatment
Table 68. Key Market Challenges & Risks of Metachromatic Leukodystrophy (MLD) Treatment
Table 69. Key Industry Trends of Metachromatic Leukodystrophy (MLD) Treatment
Table 70. Metachromatic Leukodystrophy (MLD) Treatment Raw Material
Table 71. Key Suppliers of Raw Materials
Table 72. Metachromatic Leukodystrophy (MLD) Treatment Distributors List
Table 73. Metachromatic Leukodystrophy (MLD) Treatment Customer List
Table 74. Global Metachromatic Leukodystrophy (MLD) Treatment Sales Forecast by Region (2023-2028) & (K Pcs)
Table 75. Global Metachromatic Leukodystrophy (MLD) Treatment Sales Market Forecast by Region
Table 76. Global Metachromatic Leukodystrophy (MLD) Treatment Revenue Forecast by Region (2023-2028) & ($ millions)
Table 77. Global Metachromatic Leukodystrophy (MLD) Treatment Revenue Market Share Forecast by Region (2023-2028)
Table 78. Americas Metachromatic Leukodystrophy (MLD) Treatment Sales Forecast by Country (2023-2028) & (K Pcs)
Table 79. Americas Metachromatic Leukodystrophy (MLD) Treatment Revenue Forecast by Country (2023-2028) & ($ millions)
Table 80. APAC Metachromatic Leukodystrophy (MLD) Treatment Sales Forecast by Region (2023-2028) & (K Pcs)
Table 81. APAC Metachromatic Leukodystrophy (MLD) Treatment Revenue Forecast by Region (2023-2028) & ($ millions)
Table 82. Europe Metachromatic Leukodystrophy (MLD) Treatment Sales Forecast by Country (2023-2028) & (K Pcs)
Table 83. Europe Metachromatic Leukodystrophy (MLD) Treatment Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Middle East & Africa Metachromatic Leukodystrophy (MLD) Treatment Sales Forecast by Country (2023-2028) & (K Pcs)
Table 85. Middle East & Africa Metachromatic Leukodystrophy (MLD) Treatment Revenue Forecast by Country (2023-2028) & ($ millions)
Table 86. Global Metachromatic Leukodystrophy (MLD) Treatment Sales Forecast by Type (2023-2028) & (K Pcs)
Table 87. Global Metachromatic Leukodystrophy (MLD) Treatment Sales Market Share Forecast by Type (2023-2028)
Table 88. Global Metachromatic Leukodystrophy (MLD) Treatment Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 89. Global Metachromatic Leukodystrophy (MLD) Treatment Revenue Market Share Forecast by Type (2023-2028)
Table 90. Global Metachromatic Leukodystrophy (MLD) Treatment Sales Forecast by Application (2023-2028) & (K Pcs)
Table 91. Global Metachromatic Leukodystrophy (MLD) Treatment Sales Market Share Forecast by Application (2023-2028)
Table 92. Global Metachromatic Leukodystrophy (MLD) Treatment Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 93. Global Metachromatic Leukodystrophy (MLD) Treatment Revenue Market Share Forecast by Application (2023-2028)
Table 94. ArmaGen Inc Basic Information, Metachromatic Leukodystrophy (MLD) Treatment Manufacturing Base, Sales Area and Its Competitors
Table 95. ArmaGen Inc Metachromatic Leukodystrophy (MLD) Treatment Product Offered
Table 96. ArmaGen Inc Metachromatic Leukodystrophy (MLD) Treatment Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 97. ArmaGen Inc Main Business
Table 98. ArmaGen Inc Latest Developments
Table 99. GlaxoSmithKline Plc Basic Information, Metachromatic Leukodystrophy (MLD) Treatment Manufacturing Base, Sales Area and Its Competitors
Table 100. GlaxoSmithKline Plc Metachromatic Leukodystrophy (MLD) Treatment Product Offered
Table 101. GlaxoSmithKline Plc Metachromatic Leukodystrophy (MLD) Treatment Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 102. GlaxoSmithKline Plc Main Business
Table 103. GlaxoSmithKline Plc Latest Developments
Table 104. Recursion Pharmaceuticals Inc Basic Information, Metachromatic Leukodystrophy (MLD) Treatment Manufacturing Base, Sales Area and Its Competitors
Table 105. Recursion Pharmaceuticals Inc Metachromatic Leukodystrophy (MLD) Treatment Product Offered
Table 106. Recursion Pharmaceuticals Inc Metachromatic Leukodystrophy (MLD) Treatment Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 107. Recursion Pharmaceuticals Inc Main Business
Table 108. Recursion Pharmaceuticals Inc Latest Developments
Table 109. RegenxBio Inc Basic Information, Metachromatic Leukodystrophy (MLD) Treatment Manufacturing Base, Sales Area and Its Competitors
Table 110. RegenxBio Inc Metachromatic Leukodystrophy (MLD) Treatment Product Offered
Table 111. RegenxBio Inc Metachromatic Leukodystrophy (MLD) Treatment Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 112. RegenxBio Inc Main Business
Table 113. RegenxBio Inc Latest Developments
Table 114. Takeda Basic Information, Metachromatic Leukodystrophy (MLD) Treatment Manufacturing Base, Sales Area and Its Competitors
Table 115. Takeda Metachromatic Leukodystrophy (MLD) Treatment Product Offered
Table 116. Takeda Metachromatic Leukodystrophy (MLD) Treatment Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 117. Takeda Main Business
Table 118. Takeda Latest Developments
LIST OF FIGURES
Figure 1. Picture of Metachromatic Leukodystrophy (MLD) Treatment
Figure 2. Metachromatic Leukodystrophy (MLD) Treatment Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Metachromatic Leukodystrophy (MLD) Treatment Sales Growth Rate 2017-2028 (K Pcs)
Figure 7. Global Metachromatic Leukodystrophy (MLD) Treatment Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Metachromatic Leukodystrophy (MLD) Treatment Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of AGT-183
Figure 10. Product Picture of DUOC-01
Figure 11. Product Picture of GSK-2696274
Figure 12. Product Picture of Others
Figure 13. Global Metachromatic Leukodystrophy (MLD) Treatment Sales Market Share by Type in 2021
Figure 14. Global Metachromatic Leukodystrophy (MLD) Treatment Revenue Market Share by Type (2017-2022)
Figure 15. Metachromatic Leukodystrophy (MLD) Treatment Consumed in Hospital
Figure 16. Global Metachromatic Leukodystrophy (MLD) Treatment Market: Hospital (2017-2022) & (K Pcs)
Figure 17. Metachromatic Leukodystrophy (MLD) Treatment Consumed in Clinic
Figure 18. Global Metachromatic Leukodystrophy (MLD) Treatment Market: Clinic (2017-2022) & (K Pcs)
Figure 19. Metachromatic Leukodystrophy (MLD) Treatment Consumed in Others
Figure 20. Global Metachromatic Leukodystrophy (MLD) Treatment Market: Others (2017-2022) & (K Pcs)
Figure 21. Global Metachromatic Leukodystrophy (MLD) Treatment Sales Market Share by Application (2017-2022)
Figure 22. Global Metachromatic Leukodystrophy (MLD) Treatment Revenue Market Share by Application in 2021
Figure 23. Metachromatic Leukodystrophy (MLD) Treatment Revenue Market by Company in 2021 ($ Million)
Figure 24. Global Metachromatic Leukodystrophy (MLD) Treatment Revenue Market Share by Company in 2021
Figure 25. Global Metachromatic Leukodystrophy (MLD) Treatment Sales Market Share by Geographic Region (2017-2022)
Figure 26. Global Metachromatic Leukodystrophy (MLD) Treatment Revenue Market Share by Geographic Region in 2021
Figure 27. Global Metachromatic Leukodystrophy (MLD) Treatment Sales Market Share by Region (2017-2022)
Figure 28. Global Metachromatic Leukodystrophy (MLD) Treatment Revenue Market Share by Country/Region in 2021
Figure 29. Americas Metachromatic Leukodystrophy (MLD) Treatment Sales 2017-2022 (K Pcs)
Figure 30. Americas Metachromatic Leukodystrophy (MLD) Treatment Revenue 2017-2022 ($ Millions)
Figure 31. APAC Metachromatic Leukodystrophy (MLD) Treatment Sales 2017-2022 (K Pcs)
Figure 32. APAC Metachromatic Leukodystrophy (MLD) Treatment Revenue 2017-2022 ($ Millions)
Figure 33. Europe Metachromatic Leukodystrophy (MLD) Treatment Sales 2017-2022 (K Pcs)
Figure 34. Europe Metachromatic Leukodystrophy (MLD) Treatment Revenue 2017-2022 ($ Millions)
Figure 35. Middle East & Africa Metachromatic Leukodystrophy (MLD) Treatment Sales 2017-2022 (K Pcs)
Figure 36. Middle East & Africa Metachromatic Leukodystrophy (MLD) Treatment Revenue 2017-2022 ($ Millions)
Figure 37. Americas Metachromatic Leukodystrophy (MLD) Treatment Sales Market Share by Country in 2021
Figure 38. Americas Metachromatic Leukodystrophy (MLD) Treatment Revenue Market Share by Country in 2021
Figure 39. United States Metachromatic Leukodystrophy (MLD) Treatment Revenue Growth 2017-2022 ($ Millions)
Figure 40. Canada Metachromatic Leukodystrophy (MLD) Treatment Revenue Growth 2017-2022 ($ Millions)
Figure 41. Mexico Metachromatic Leukodystrophy (MLD) Treatment Revenue Growth 2017-2022 ($ Millions)
Figure 42. Brazil Metachromatic Leukodystrophy (MLD) Treatment Revenue Growth 2017-2022 ($ Millions)
Figure 43. APAC Metachromatic Leukodystrophy (MLD) Treatment Sales Market Share by Region in 2021
Figure 44. APAC Metachromatic Leukodystrophy (MLD) Treatment Revenue Market Share by Regions in 2021
Figure 45. China Metachromatic Leukodystrophy (MLD) Treatment Revenue Growth 2017-2022 ($ Millions)
Figure 46. Japan Metachromatic Leukodystrophy (MLD) Treatment Revenue Growth 2017-2022 ($ Millions)
Figure 47. South Korea Metachromatic Leukodystrophy (MLD) Treatment Revenue Growth 2017-2022 ($ Millions)
Figure 48. Southeast Asia Metachromatic Leukodystrophy (MLD) Treatment Revenue Growth 2017-2022 ($ Millions)
Figure 49. India Metachromatic Leukodystrophy (MLD) Treatment Revenue Growth 2017-2022 ($ Millions)
Figure 50. Australia Metachromatic Leukodystrophy (MLD) Treatment Revenue Growth 2017-2022 ($ Millions)
Figure 51. Europe Metachromatic Leukodystrophy (MLD) Treatment Sales Market Share by Country in 2021
Figure 52. Europe Metachromatic Leukodystrophy (MLD) Treatment Revenue Market Share by Country in 2021
Figure 53. Germany Metachromatic Leukodystrophy (MLD) Treatment Revenue Growth 2017-2022 ($ Millions)
Figure 54. France Metachromatic Leukodystrophy (MLD) Treatment Revenue Growth 2017-2022 ($ Millions)
Figure 55. UK Metachromatic Leukodystrophy (MLD) Treatment Revenue Growth 2017-2022 ($ Millions)
Figure 56. Italy Metachromatic Leukodystrophy (MLD) Treatment Revenue Growth 2017-2022 ($ Millions)
Figure 57. Russia Metachromatic Leukodystrophy (MLD) Treatment Revenue Growth 2017-2022 ($ Millions)
Figure 58. Middle East & Africa Metachromatic Leukodystrophy (MLD) Treatment Sales Market Share by Country in 2021
Figure 59. Middle East & Africa Metachromatic Leukodystrophy (MLD) Treatment Revenue Market Share by Country in 2021
Figure 60. Egypt Metachromatic Leukodystrophy (MLD) Treatment Revenue Growth 2017-2022 ($ Millions)
Figure 61. South Africa Metachromatic Leukodystrophy (MLD) Treatment Revenue Growth 2017-2022 ($ Millions)
Figure 62. Israel Metachromatic Leukodystrophy (MLD) Treatment Revenue Growth 2017-2022 ($ Millions)
Figure 63. Turkey Metachromatic Leukodystrophy (MLD) Treatment Revenue Growth 2017-2022 ($ Millions)
Figure 64. GCC Country Metachromatic Leukodystrophy (MLD) Treatment Revenue Growth 2017-2022 ($ Millions)
Figure 65. Manufacturing Cost Structure Analysis of Metachromatic Leukodystrophy (MLD) Treatment in 2021
Figure 66. Manufacturing Process Analysis of Metachromatic Leukodystrophy (MLD) Treatment
Figure 67. Industry Chain Structure of Metachromatic Leukodystrophy (MLD) Treatment
Figure 68. Channels of Distribution
Figure 69. Distributors Profiles
Figure 1. Picture of Metachromatic Leukodystrophy (MLD) Treatment
Figure 2. Metachromatic Leukodystrophy (MLD) Treatment Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Metachromatic Leukodystrophy (MLD) Treatment Sales Growth Rate 2017-2028 (K Pcs)
Figure 7. Global Metachromatic Leukodystrophy (MLD) Treatment Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Metachromatic Leukodystrophy (MLD) Treatment Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of AGT-183
Figure 10. Product Picture of DUOC-01
Figure 11. Product Picture of GSK-2696274
Figure 12. Product Picture of Others
Figure 13. Global Metachromatic Leukodystrophy (MLD) Treatment Sales Market Share by Type in 2021
Figure 14. Global Metachromatic Leukodystrophy (MLD) Treatment Revenue Market Share by Type (2017-2022)
Figure 15. Metachromatic Leukodystrophy (MLD) Treatment Consumed in Hospital
Figure 16. Global Metachromatic Leukodystrophy (MLD) Treatment Market: Hospital (2017-2022) & (K Pcs)
Figure 17. Metachromatic Leukodystrophy (MLD) Treatment Consumed in Clinic
Figure 18. Global Metachromatic Leukodystrophy (MLD) Treatment Market: Clinic (2017-2022) & (K Pcs)
Figure 19. Metachromatic Leukodystrophy (MLD) Treatment Consumed in Others
Figure 20. Global Metachromatic Leukodystrophy (MLD) Treatment Market: Others (2017-2022) & (K Pcs)
Figure 21. Global Metachromatic Leukodystrophy (MLD) Treatment Sales Market Share by Application (2017-2022)
Figure 22. Global Metachromatic Leukodystrophy (MLD) Treatment Revenue Market Share by Application in 2021
Figure 23. Metachromatic Leukodystrophy (MLD) Treatment Revenue Market by Company in 2021 ($ Million)
Figure 24. Global Metachromatic Leukodystrophy (MLD) Treatment Revenue Market Share by Company in 2021
Figure 25. Global Metachromatic Leukodystrophy (MLD) Treatment Sales Market Share by Geographic Region (2017-2022)
Figure 26. Global Metachromatic Leukodystrophy (MLD) Treatment Revenue Market Share by Geographic Region in 2021
Figure 27. Global Metachromatic Leukodystrophy (MLD) Treatment Sales Market Share by Region (2017-2022)
Figure 28. Global Metachromatic Leukodystrophy (MLD) Treatment Revenue Market Share by Country/Region in 2021
Figure 29. Americas Metachromatic Leukodystrophy (MLD) Treatment Sales 2017-2022 (K Pcs)
Figure 30. Americas Metachromatic Leukodystrophy (MLD) Treatment Revenue 2017-2022 ($ Millions)
Figure 31. APAC Metachromatic Leukodystrophy (MLD) Treatment Sales 2017-2022 (K Pcs)
Figure 32. APAC Metachromatic Leukodystrophy (MLD) Treatment Revenue 2017-2022 ($ Millions)
Figure 33. Europe Metachromatic Leukodystrophy (MLD) Treatment Sales 2017-2022 (K Pcs)
Figure 34. Europe Metachromatic Leukodystrophy (MLD) Treatment Revenue 2017-2022 ($ Millions)
Figure 35. Middle East & Africa Metachromatic Leukodystrophy (MLD) Treatment Sales 2017-2022 (K Pcs)
Figure 36. Middle East & Africa Metachromatic Leukodystrophy (MLD) Treatment Revenue 2017-2022 ($ Millions)
Figure 37. Americas Metachromatic Leukodystrophy (MLD) Treatment Sales Market Share by Country in 2021
Figure 38. Americas Metachromatic Leukodystrophy (MLD) Treatment Revenue Market Share by Country in 2021
Figure 39. United States Metachromatic Leukodystrophy (MLD) Treatment Revenue Growth 2017-2022 ($ Millions)
Figure 40. Canada Metachromatic Leukodystrophy (MLD) Treatment Revenue Growth 2017-2022 ($ Millions)
Figure 41. Mexico Metachromatic Leukodystrophy (MLD) Treatment Revenue Growth 2017-2022 ($ Millions)
Figure 42. Brazil Metachromatic Leukodystrophy (MLD) Treatment Revenue Growth 2017-2022 ($ Millions)
Figure 43. APAC Metachromatic Leukodystrophy (MLD) Treatment Sales Market Share by Region in 2021
Figure 44. APAC Metachromatic Leukodystrophy (MLD) Treatment Revenue Market Share by Regions in 2021
Figure 45. China Metachromatic Leukodystrophy (MLD) Treatment Revenue Growth 2017-2022 ($ Millions)
Figure 46. Japan Metachromatic Leukodystrophy (MLD) Treatment Revenue Growth 2017-2022 ($ Millions)
Figure 47. South Korea Metachromatic Leukodystrophy (MLD) Treatment Revenue Growth 2017-2022 ($ Millions)
Figure 48. Southeast Asia Metachromatic Leukodystrophy (MLD) Treatment Revenue Growth 2017-2022 ($ Millions)
Figure 49. India Metachromatic Leukodystrophy (MLD) Treatment Revenue Growth 2017-2022 ($ Millions)
Figure 50. Australia Metachromatic Leukodystrophy (MLD) Treatment Revenue Growth 2017-2022 ($ Millions)
Figure 51. Europe Metachromatic Leukodystrophy (MLD) Treatment Sales Market Share by Country in 2021
Figure 52. Europe Metachromatic Leukodystrophy (MLD) Treatment Revenue Market Share by Country in 2021
Figure 53. Germany Metachromatic Leukodystrophy (MLD) Treatment Revenue Growth 2017-2022 ($ Millions)
Figure 54. France Metachromatic Leukodystrophy (MLD) Treatment Revenue Growth 2017-2022 ($ Millions)
Figure 55. UK Metachromatic Leukodystrophy (MLD) Treatment Revenue Growth 2017-2022 ($ Millions)
Figure 56. Italy Metachromatic Leukodystrophy (MLD) Treatment Revenue Growth 2017-2022 ($ Millions)
Figure 57. Russia Metachromatic Leukodystrophy (MLD) Treatment Revenue Growth 2017-2022 ($ Millions)
Figure 58. Middle East & Africa Metachromatic Leukodystrophy (MLD) Treatment Sales Market Share by Country in 2021
Figure 59. Middle East & Africa Metachromatic Leukodystrophy (MLD) Treatment Revenue Market Share by Country in 2021
Figure 60. Egypt Metachromatic Leukodystrophy (MLD) Treatment Revenue Growth 2017-2022 ($ Millions)
Figure 61. South Africa Metachromatic Leukodystrophy (MLD) Treatment Revenue Growth 2017-2022 ($ Millions)
Figure 62. Israel Metachromatic Leukodystrophy (MLD) Treatment Revenue Growth 2017-2022 ($ Millions)
Figure 63. Turkey Metachromatic Leukodystrophy (MLD) Treatment Revenue Growth 2017-2022 ($ Millions)
Figure 64. GCC Country Metachromatic Leukodystrophy (MLD) Treatment Revenue Growth 2017-2022 ($ Millions)
Figure 65. Manufacturing Cost Structure Analysis of Metachromatic Leukodystrophy (MLD) Treatment in 2021
Figure 66. Manufacturing Process Analysis of Metachromatic Leukodystrophy (MLD) Treatment
Figure 67. Industry Chain Structure of Metachromatic Leukodystrophy (MLD) Treatment
Figure 68. Channels of Distribution
Figure 69. Distributors Profiles
